Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis

Metabolomic Differences between the Skin and Blood Sera of Atopic Dermatitis and Psoriasis

(2022) Liis Ilves et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab

(2022) Lishan Zhang et al.   Frontiers in Immunology

Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response

(2021) E. Nettis et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Japanese guidelines for atopic dermatitis 2020

(2020) Norito Katoh et al.   ALLERGOLOGY INTERNATIONAL

Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience

(2020) Silvia Ferrucci et al.   Journal of Clinical Medicine

Analysis of non‐responders to dupilumab in clinical practice: a cohort study

(2020) C. Linder et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre

(2019) C.M. Olesen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

(2019) Lieneke F. M. Ariëns et al.   ALLERGY

Poly-ADP ribose polymerase-14 limits severity of allergic skin disease

(2017) Purna Krishnamurthy et al.   IMMUNOLOGY

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

(2017) Andrew Blauvelt et al.   LANCET

Metabolic roles of poly(ADP-ribose) polymerases

(2017) András Vida et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation

(2017) Aigar Ottas et al.   PLoS One

Higher maternal serum concentrations of nicotinamide and related metabolites in late pregnancy are associated with a lower risk of offspring atopic eczema at age 12 months

(2016) S. El-Heis et al.   CLINICAL AND EXPERIMENTAL ALLERGY

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

(2016) A. Wollenberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Serum Metabolomics Study and Eicosanoid Analysis of Childhood Atopic Dermatitis Based on Liquid Chromatography–Mass Spectrometry

(2014) Yan Huang et al.   JOURNAL OF PROTEOME RESEARCH

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

(2014) Lisa A. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines

(2013) M. Hotze et al.   ALLERGY

The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients

(2013) Jeroen van Smeden et al.   EXPERIMENTAL DERMATOLOGY

Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography–mass spectrometry

(2011) Masaru Yoshida et al.   JOURNAL OF GASTROENTEROLOGY

Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis

(2010) Chiung-Hui Yen et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY